Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Sutro Biopharma (STRO) Long-Term Debt Issuances (2020)

Sutro Biopharma's Long-Term Debt Issuances history spans 1 years, with the latest figure at $25.0 million for Q1 2020.

  • For Q1 2020, Long-Term Debt Issuances changed N/A year-over-year to $25.0 million; the TTM value through Dec 2020 reached $25.0 million, changed N/A, while the annual FY2020 figure was $25.0 million, N/A changed from the prior year.
  • Long-Term Debt Issuances for Q1 2020 was $25.0 million at Sutro Biopharma.
  • Across five years, Long-Term Debt Issuances topped out at $25.0 million in Q1 2020 and bottomed at $25.0 million in Q1 2020.